TSPO and glioblastoma: In particular, [18F]CB251 displayed reasonable tumour uptake in the human glioblastoma U87-MG xenograft model (1.96 ± 0.11%ID/g at 1 h post injection) and was comparable to accumulation of other TSPO ligands27.